Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 5,000 shares at $48.58 ($244K) on 2024-02-15, disclosed to the SEC on 2024-02-20.
Scheduled sale ($244k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.58 | 3,300 | $160K | 65.6% |
| 2 | $49.43 | 1,700 | $84K | 34.4% |
| Total | $48.87 avg | 5,000 | $244K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |